TACSTD2 and Familial prostate cancer: In our previous study, we demonstrated that high levels of tissue Trop2 predict a shorter time to recurrence in a prostate cancer cohort with 234 patients, suggesting that Trop2 could serve as a prognostic tissue biomarker for early detection of clinically significant localized prostate cancer15.